Adrenal insufficiency in critical patients: New ethiopathogenic concepts and therapeutic implications
- PMID: 29137961
- DOI: 10.1016/j.endinu.2017.09.004
Adrenal insufficiency in critical patients: New ethiopathogenic concepts and therapeutic implications
Abstract
Recently, there have been advances in understanding of the changes that occur in the hypothalamic-pituitary-adrenal axis during the different stages of critical disease. Such advances have led to a paradigm change, so that the aforementioned adaptations are no longer considered the result of adrenal axis activation, but a consequence of decreased cortisol metabolism illness. Knowledge of this new pathophysiological bases should lead to reconsider the diagnosis and treatment of adrenal insufficiency in critically ill patients, a condition poorly understood to date.
Keywords: Adrenal insufficiency; Cortisol metabolism; Critical patient; Enfermo crítico; Insuficiencia suprarrenal; Metabolismo del cortisol.
Copyright © 2017 SEEN y SED. Publicado por Elsevier España, S.L.U. All rights reserved.
Similar articles
-
The hypothalamic-pituitary-adrenal axis in critical illness.AACN Clin Issues. 2006 Jan-Mar;17(1):39-49. doi: 10.1097/00044067-200601000-00006. AACN Clin Issues. 2006. PMID: 16462408 Review.
-
Hypothalamic-pituitary-adrenal insufficiency.Crit Care Clin. 2001 Jan;17(1):25-41. doi: 10.1016/s0749-0704(05)70150-0. Crit Care Clin. 2001. PMID: 11219233 Review.
-
[Corticosteroid administration for critically ill patients].Ned Tijdschr Geneeskd. 2001 Sep 8;145(36):1725-9. Ned Tijdschr Geneeskd. 2001. PMID: 11572171 Review. Dutch.
-
MECHANISMS IN ENDOCRINOLOGY: New concepts to further unravel adrenal insufficiency during critical illness.Eur J Endocrinol. 2016 Jul;175(1):R1-9. doi: 10.1530/EJE-15-1098. Epub 2016 Jan 25. Eur J Endocrinol. 2016. PMID: 26811405 Review.
-
Corticosteroid insufficiency in acutely ill patients.N Engl J Med. 2003 Feb 20;348(8):727-34. doi: 10.1056/NEJMra020529. N Engl J Med. 2003. PMID: 12594318 Review. No abstract available.
Cited by
-
Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients.Trials. 2022 Feb 14;23(1):148. doi: 10.1186/s13063-022-06075-5. Trials. 2022. PMID: 35164840 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources